Lincoln Park Bancorp (LPBC) 6.5000 $LPBC
Poll Shows Americans Deeply Concerned about Online Privacy, Mistrust Social Media
PR Newswire - Thu Jul 31, 7:30AM CDT
Almost three-quarters of Americans worry about the quantity of personal information available online and more than half feel they cannot trust social media sites like Facebook and Twitter to keep their contact information, buying habits and political beliefs confidential, according to new poll data released today at http://www.onlineprivacydata.org.
Biodel signs USD15m equity agreement with Lincoln Park Capital
M2 - Mon Jul 28, 6:24AM CDT
Biopharmaceutical company Biodel (NasdaqCM:BIOD) revealed on Monday the execution of a USD15m stock purchase agreement with Lincoln Park Capital Fund (LPC), a Chicago-based institutional investor.
Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital
Marketwire - Mon Jul 28, 5:00AM CDT
Biodel Inc. (NASDAQ: BIOD) today announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"
, a Chicago-based institutional investor. Under the terms of the purchase agreement, Biodel will have the right to sell to LPC, and LPC will be obligated to purchase, up to $15 million in shares of Biodel's common stock, subject to the limitations and conditions set forth in the agreement. Biodel intends to use any proceeds that it receives from the sale of shares under the purchase agreement for general corporate purposes and working capital requirements.
Miller-Valentine Group Proudly Announces the 25th Anniversary of Lincoln Park Manor in Kettering, Ohio
PRWeb - Wed Jul 16, 1:36PM CDT
This year marks the 25th anniversary of Lincoln Park Manor as their first patient was admitted on July 17, 1989. Lincoln Park Manor is owned by Miller-Valentine Group, a trusted name in Dayton and many communities. Together they have built a reputation of integrity and best business practices. Every day the staff at Lincoln Park Manor lives up to these expectations and strives to exceed them. Their dedication has been acknowledged by achieving a deficiency free health survey for the last two consecutive annual surveys conducted by the Ohio Department of Health and a 5 Star Rating with Medicare.
Advanced Cell Technology Secures $30 Million Equity Facility from Lincoln Park Capital
Business Wire - Thu Jul 03, 8:05AM CDT
Advanced Cell Technology, Inc. ("ACT" (OTCBB:ACTC), a leader in the field of regenerative medicine, today announced that it has entered into a $30 million common stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC" .
New Poll Details Widespread Harassment Online, Especially on Facebook
PR Newswire - Wed Jun 04, 7:30AM CDT
Almost 50% of Americans under the age of 35 have been bullied, harassed or threatened online, or know somebody who has, according to a new poll published today exposing the ugly underbelly of social media. Women are targeted more often than men, and Facebook is by far the most common forum for such harassment.
KonaRed Corporation Raises First $500,000 from $12 Million Equity Line
PR Newswire - Mon Jun 02, 8:02AM CDT
KonaRed Corporation (OTCBB/OTCQB: KRED), manufacturers of Antioxidant Juices from the exclusive Hawaiian CoffeeBerry®, coffee fruit from Kona, Hawaii, announced today it has completed a drawdown of $500,000 of the $12 million Equity Line in place with Lincoln Park Capital Fund LLC.
BioLineRx Enters into Share Purchase Agreement with Lincoln Park Capital
Business Wire - Fri May 30, 8:19AM CDT
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has signed a purchase agreement for the sale, from time to time, of up to $20 million of its American Depositary Shares ("ADSs" with Lincoln Park Capital Fund, LLC ("LPC" , a Chicago-based institutional investor.
Nuvilex Enters Into an At the Market Banking Agreement With Chardan Capital Markets
GlobeNewswire - Thu May 29, 9:02AM CDT
Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that it has entered into an "At the Market" banking agreement with Chardan Capital Markets, LLC under which Nuvilex may seek to raise up to a total of $50,000,000 depending upon market conditions and at the discretion of Nuvilex. In the banking agreement, Chardan Capital Markets will act as the exclusive placement agent for Nuvilex. The funds will be used for: (i) late-phase clinical trials in pancreatic cancer with Clinical Network Services (CNS) in Australia; (ii) preclinical studies and clinical trials with Translational Drug Development (TD2) to address the symptoms of pancreatic cancer to be conducted in the U.S.; and (iii) further testing and research for diabetes in Europe.
AuctionWorks to Host Real Estate Auction June 23-25
Business Wire - Tue May 27, 11:43AM CDT
AuctionWorks has announced the firm will host an auction online June 23-25 that will include single-family, multi-family, mixed-use, office, industrial, retail and vacant land. The auction includes two luxury homes in Chicago's Lincoln Park and Peterson Park neighborhoods. Also, six of the 27 properties currently offered are bank-owned and will be sold absolute to the highest bidder, regardless of price. Buyers can bid online or submit pre-auction offers.
Acer Announces Extreme Technology Makeover Program Winner
PRWeb - Thu May 22, 7:07AM CDT
Editor's Summary: James R. Moran Middle School of Wallingford, CT is the winner of the Acer Extreme Classroom Technology Makeover. Program offered schools in the U.S. the chance to transform their classrooms with immersive tablet technology. The contest winner, selected by public voting, is receiving a classroom set of 30 Acer Iconia W Series tablets with a retail value of $15,000. Acer America today announced James R. Moran Middle School in Wallingford, CT as the winner of its Acer Extreme Classroom Technology Makeover. As the winner, they will receive a classroom set of 30 Acer Iconia W Series tablets with an approximate retail value of $15,000. This program provided K-12 schools in the U.S. the opportunity to transform a classroom with immersive tablet technology. Tablets enhance the learning experience by making it more hands-on, interactive and engaging as well as encouraging collaboration and to explore more. "We're delighted to award James R. Moran Middle School with a classroom set of tablets," said Rich Black, Acer America senior director of marketing. "Their video submission showcased the deep passion these students and teachers have for technology and learning. We're certain the Iconia W tablets will further increase student engagement by making lesson plans more interesting, and providing them relevant experience using the same tools that are used in the marketplace today." James R. Moran Middle School received the most votes from the public who chose one school as the winner from among 10 finalists, which also included: A.B. Davis Middle School, Mt. Vernon, NY Altruria Elementary, Bartlett, TN Barton Elementary School, Patchogue, NY James R. Watson Elementary, Auburn, IN Leicester Memorial School, Leicester, MA Lincoln Park Middle School, Lincoln Park, NJ Lytle High School, Lytle, Texas MacMillan International Academy for Humanities and Technology, Montgomery, AL Wyland Elementary School, St. Louis, MO To view the winner's video entry, click on the following link. http://professional.us.acer.com/edu/campaign/.../index.htm The contest was open to educators for K-12 students in the United States with one entry permissible per school. Educators were invited to submit a summary using video, images or text describing why their classroom deserves a makeover and were encouraged to collaborate with their students. The summary was to demonstrate how they would use tablets to enhance the learning experience in their classroom and help students explore more. About Acer Established in 1976, Acer is a hardware + software + services company dedicated to the research, design, marketing, sale and support of innovative products that enhance people's lives. Acer's product offering includes PCs, displays, projectors, servers, tablets and smartphones -- tools our customers need to explore beyond limits and experience more. Acer employs 7,400 people and ranks No. 4 for total PCs globally.* Revenues for 2013 reached US$12.02 billion. Please visit http://www.acer.com for more information. © 2014 Acer America Corp. All rights reserved. Acer and the Acer logo are registered trademarks of Acer Inc. Other trademarks, registered trademarks, and/or service marks, indicated or otherwise, are the property of their respective owners. All offers subject to change without notice or obligation and may not be available through all sales channels. Prices listed are manufacturer suggested retail prices and may vary by location. Applicable sales tax extra. IDC 2013
Amarantus Reports First Quarter 2014 Financial Results
GlobeNewswire - Wed May 21, 7:15AM CDT
Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, today reported financial results for the first quarter ended March 31, 2014. At March 31, 2014, the Company had cash and cash equivalents totaling approximately $3.8 million.
Amarantus BioScience Holdings, Inc. "Transformational Funding Positions Amarantus Heading into 2014 Milestones"
ACCESSWIRE - Mon Mar 10, 12:46PM CDT
New York, NY / ACCESSWIRE / March 10, 2014 / Amarantus BioScience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman's Blog, written by the Company's CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
GlobeNewswire - Mon Mar 10, 5:00AM CDT
Amarantus Bioscience Holdings, Inc. (OTC:AMBS) (Amarantus or the Company), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, announced today that it has closed on its previously announced Warrant Solicitation, which the Company elected to increase in size from $3.0M to $3.6M due to oversubscriptions. Concurrently, the Company entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC" , a Chicago-based institutional investor. LPC initially purchased 4.0 million shares of Amarantus' common stock at $0.10 per share for $400,000 and has committed to invest, at the sole option of Amarantus, up to an additional $19.6M of equity capital over the term of the purchase agreement. The total gross proceeds to the Company from these two transactions upon closing is $4M.
Experience the Difference at Lincoln Park Manor; Recognized for Deficiency-Free Health Survey
PRWeb - Sat Mar 08, 11:45AM CST
Russ Holtz, Executive Director of Lincoln Mark Manor, is proud of the 2014 survey results and is honored with the overall 5-Star rating from Medicare. Holtz states, "We have maintained this outstanding accomplishment for the second consecutive year. We understand the importance of having an amazing, caring team of staff members who continue to play a key role towards this distinction year after year."
PourMyBeer™ Revolutionizes Beer Service in Chicago with Introduction of Self-Serve System
PRWeb - Fri Mar 07, 5:05AM CST
Craft beer is at an all-time high and customer demand for beer means the need to serve them more quickly, efficiently and responsibly is greater than ever. Enter the PourMyBeer™ system. It conveniently allows customers to purchase and pour their own beer, with staff interaction and oversight of course. It also allows customers to pay only for what they drink, instead of a packaged or predetermined amount. By reserving a PourMyBeer™ table, customers can guarantee favorite draft beers will be on tap for the night.
Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC
PR Newswire - Thu Feb 27, 8:26AM CST
Oncolytics Biotech Inc. ("Oncolytics" or the "Company" (TSX:ONC; NASDAQ:ONCY) announced today that it has entered into a share purchase agreement (the "Purchase Agreement" with Lincoln Park Capital Fund, LLC ("LPC" that will provide an initial investment in Oncolytics of US$1.0 million and make available additional periodic investments of up to US$25.0 million over a 30-month term (the "Financing" .
Facebook CEO says WhatsAPP Worth More than $19B; Lincoln Park Capital Invests in Nuvilex
ACCESSWIRE - Tue Feb 25, 3:48AM CST
Verizon Communications Inc. (NYSE: VZ) - For an in-depth report on Verizon Communications Inc. follow: www.BullTrends.com/stockquote/VZ
Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly
Marketwire - Mon Feb 24, 8:04AM CST
Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be viewed as a $27 million "pot of money" to advance the company's late-phase pancreatic cancer clinical trials. Notice we said restricted shares, that's right, LPC has put a great deal of its money on the line with a number of built in protections for Nuvilex. But, is this investment really a risk? It appears the Chicago-based firm knows exactly what the future could hold for Nuvilex, and they're comfortable with paying a premium price to become a long-term investor right along with many others who believe in the small biotechnology firm.
Poll Shows Americans Deeply Concerned about Online Privacy, Mistrust Social Media
PR Newswire - Thu Jul 31, 7:30AM CDT
Almost three-quarters of Americans worry about the quantity of personal information available online and more than half feel they cannot trust social media sites like Facebook and Twitter to keep their contact information, buying habits and political beliefs confidential, according to new poll data released today at http://www.onlineprivacydata.org.
Biodel signs USD15m equity agreement with Lincoln Park Capital
M2 - Mon Jul 28, 6:24AM CDT
Biopharmaceutical company Biodel (NasdaqCM:BIOD) revealed on Monday the execution of a USD15m stock purchase agreement with Lincoln Park Capital Fund (LPC), a Chicago-based institutional investor.
Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital
Marketwire - Mon Jul 28, 5:00AM CDT
Biodel Inc. (NASDAQ: BIOD) today announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"
, a Chicago-based institutional investor. Under the terms of the purchase agreement, Biodel will have the right to sell to LPC, and LPC will be obligated to purchase, up to $15 million in shares of Biodel's common stock, subject to the limitations and conditions set forth in the agreement. Biodel intends to use any proceeds that it receives from the sale of shares under the purchase agreement for general corporate purposes and working capital requirements. Miller-Valentine Group Proudly Announces the 25th Anniversary of Lincoln Park Manor in Kettering, Ohio
PRWeb - Wed Jul 16, 1:36PM CDT
This year marks the 25th anniversary of Lincoln Park Manor as their first patient was admitted on July 17, 1989. Lincoln Park Manor is owned by Miller-Valentine Group, a trusted name in Dayton and many communities. Together they have built a reputation of integrity and best business practices. Every day the staff at Lincoln Park Manor lives up to these expectations and strives to exceed them. Their dedication has been acknowledged by achieving a deficiency free health survey for the last two consecutive annual surveys conducted by the Ohio Department of Health and a 5 Star Rating with Medicare.
Advanced Cell Technology Secures $30 Million Equity Facility from Lincoln Park Capital
Business Wire - Thu Jul 03, 8:05AM CDT
Advanced Cell Technology, Inc. ("ACT"
(OTCBB:ACTC), a leader in the field of regenerative medicine, today announced that it has entered into a $30 million common stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC" . New Poll Details Widespread Harassment Online, Especially on Facebook
PR Newswire - Wed Jun 04, 7:30AM CDT
Almost 50% of Americans under the age of 35 have been bullied, harassed or threatened online, or know somebody who has, according to a new poll published today exposing the ugly underbelly of social media. Women are targeted more often than men, and Facebook is by far the most common forum for such harassment.
KonaRed Corporation Raises First $500,000 from $12 Million Equity Line
PR Newswire - Mon Jun 02, 8:02AM CDT
KonaRed Corporation (OTCBB/OTCQB: KRED), manufacturers of Antioxidant Juices from the exclusive Hawaiian CoffeeBerry®, coffee fruit from Kona, Hawaii, announced today it has completed a drawdown of $500,000 of the $12 million Equity Line in place with Lincoln Park Capital Fund LLC.
BioLineRx Enters into Share Purchase Agreement with Lincoln Park Capital
Business Wire - Fri May 30, 8:19AM CDT
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has signed a purchase agreement for the sale, from time to time, of up to $20 million of its American Depositary Shares ("ADSs"
with Lincoln Park Capital Fund, LLC ("LPC" , a Chicago-based institutional investor. Nuvilex Enters Into an At the Market Banking Agreement With Chardan Capital Markets
GlobeNewswire - Thu May 29, 9:02AM CDT
Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that it has entered into an "At the Market" banking agreement with Chardan Capital Markets, LLC under which Nuvilex may seek to raise up to a total of $50,000,000 depending upon market conditions and at the discretion of Nuvilex. In the banking agreement, Chardan Capital Markets will act as the exclusive placement agent for Nuvilex. The funds will be used for: (i) late-phase clinical trials in pancreatic cancer with Clinical Network Services (CNS) in Australia; (ii) preclinical studies and clinical trials with Translational Drug Development (TD2) to address the symptoms of pancreatic cancer to be conducted in the U.S.; and (iii) further testing and research for diabetes in Europe.
AuctionWorks to Host Real Estate Auction June 23-25
Business Wire - Tue May 27, 11:43AM CDT
AuctionWorks has announced the firm will host an auction online June 23-25 that will include single-family, multi-family, mixed-use, office, industrial, retail and vacant land. The auction includes two luxury homes in Chicago's Lincoln Park and Peterson Park neighborhoods. Also, six of the 27 properties currently offered are bank-owned and will be sold absolute to the highest bidder, regardless of price. Buyers can bid online or submit pre-auction offers.
Acer Announces Extreme Technology Makeover Program Winner
PRWeb - Thu May 22, 7:07AM CDT
Editor's Summary: James R. Moran Middle School of Wallingford, CT is the winner of the Acer Extreme Classroom Technology Makeover. Program offered schools in the U.S. the chance to transform their classrooms with immersive tablet technology. The contest winner, selected by public voting, is receiving a classroom set of 30 Acer Iconia W Series tablets with a retail value of $15,000. Acer America today announced James R. Moran Middle School in Wallingford, CT as the winner of its Acer Extreme Classroom Technology Makeover. As the winner, they will receive a classroom set of 30 Acer Iconia W Series tablets with an approximate retail value of $15,000. This program provided K-12 schools in the U.S. the opportunity to transform a classroom with immersive tablet technology. Tablets enhance the learning experience by making it more hands-on, interactive and engaging as well as encouraging collaboration and to explore more. "We're delighted to award James R. Moran Middle School with a classroom set of tablets," said Rich Black, Acer America senior director of marketing. "Their video submission showcased the deep passion these students and teachers have for technology and learning. We're certain the Iconia W tablets will further increase student engagement by making lesson plans more interesting, and providing them relevant experience using the same tools that are used in the marketplace today." James R. Moran Middle School received the most votes from the public who chose one school as the winner from among 10 finalists, which also included: A.B. Davis Middle School, Mt. Vernon, NY Altruria Elementary, Bartlett, TN Barton Elementary School, Patchogue, NY James R. Watson Elementary, Auburn, IN Leicester Memorial School, Leicester, MA Lincoln Park Middle School, Lincoln Park, NJ Lytle High School, Lytle, Texas MacMillan International Academy for Humanities and Technology, Montgomery, AL Wyland Elementary School, St. Louis, MO To view the winner's video entry, click on the following link. http://professional.us.acer.com/edu/campaign/.../index.htm The contest was open to educators for K-12 students in the United States with one entry permissible per school. Educators were invited to submit a summary using video, images or text describing why their classroom deserves a makeover and were encouraged to collaborate with their students. The summary was to demonstrate how they would use tablets to enhance the learning experience in their classroom and help students explore more. About Acer Established in 1976, Acer is a hardware + software + services company dedicated to the research, design, marketing, sale and support of innovative products that enhance people's lives. Acer's product offering includes PCs, displays, projectors, servers, tablets and smartphones -- tools our customers need to explore beyond limits and experience more. Acer employs 7,400 people and ranks No. 4 for total PCs globally.* Revenues for 2013 reached US$12.02 billion. Please visit http://www.acer.com for more information. © 2014 Acer America Corp. All rights reserved. Acer and the Acer logo are registered trademarks of Acer Inc. Other trademarks, registered trademarks, and/or service marks, indicated or otherwise, are the property of their respective owners. All offers subject to change without notice or obligation and may not be available through all sales channels. Prices listed are manufacturer suggested retail prices and may vary by location. Applicable sales tax extra. IDC 2013
Amarantus Reports First Quarter 2014 Financial Results
GlobeNewswire - Wed May 21, 7:15AM CDT
Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, today reported financial results for the first quarter ended March 31, 2014. At March 31, 2014, the Company had cash and cash equivalents totaling approximately $3.8 million.
Amarantus BioScience Holdings, Inc. "Transformational Funding Positions Amarantus Heading into 2014 Milestones"
ACCESSWIRE - Mon Mar 10, 12:46PM CDT
New York, NY / ACCESSWIRE / March 10, 2014 / Amarantus BioScience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman's Blog, written by the Company's CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
GlobeNewswire - Mon Mar 10, 5:00AM CDT
Amarantus Bioscience Holdings, Inc. (OTC:AMBS) (Amarantus or the Company), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, announced today that it has closed on its previously announced Warrant Solicitation, which the Company elected to increase in size from $3.0M to $3.6M due to oversubscriptions. Concurrently, the Company entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"
, a Chicago-based institutional investor. LPC initially purchased 4.0 million shares of Amarantus' common stock at $0.10 per share for $400,000 and has committed to invest, at the sole option of Amarantus, up to an additional $19.6M of equity capital over the term of the purchase agreement. The total gross proceeds to the Company from these two transactions upon closing is $4M. Experience the Difference at Lincoln Park Manor; Recognized for Deficiency-Free Health Survey
PRWeb - Sat Mar 08, 11:45AM CST
Russ Holtz, Executive Director of Lincoln Mark Manor, is proud of the 2014 survey results and is honored with the overall 5-Star rating from Medicare. Holtz states, "We have maintained this outstanding accomplishment for the second consecutive year. We understand the importance of having an amazing, caring team of staff members who continue to play a key role towards this distinction year after year."
PourMyBeer™ Revolutionizes Beer Service in Chicago with Introduction of Self-Serve System
PRWeb - Fri Mar 07, 5:05AM CST
Craft beer is at an all-time high and customer demand for beer means the need to serve them more quickly, efficiently and responsibly is greater than ever. Enter the PourMyBeer™ system. It conveniently allows customers to purchase and pour their own beer, with staff interaction and oversight of course. It also allows customers to pay only for what they drink, instead of a packaged or predetermined amount. By reserving a PourMyBeer™ table, customers can guarantee favorite draft beers will be on tap for the night.
Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC
PR Newswire - Thu Feb 27, 8:26AM CST
Oncolytics Biotech Inc. ("Oncolytics" or the "Company"
(TSX:ONC; NASDAQ:ONCY) announced today that it has entered into a share purchase agreement (the "Purchase Agreement" with Lincoln Park Capital Fund, LLC ("LPC" that will provide an initial investment in Oncolytics of US$1.0 million and make available additional periodic investments of up to US$25.0 million over a 30-month term (the "Financing" . Facebook CEO says WhatsAPP Worth More than $19B; Lincoln Park Capital Invests in Nuvilex
ACCESSWIRE - Tue Feb 25, 3:48AM CST
Verizon Communications Inc. (NYSE: VZ) - For an in-depth report on Verizon Communications Inc. follow: www.BullTrends.com/stockquote/VZ
Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly
Marketwire - Mon Feb 24, 8:04AM CST
Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be viewed as a $27 million "pot of money" to advance the company's late-phase pancreatic cancer clinical trials. Notice we said restricted shares, that's right, LPC has put a great deal of its money on the line with a number of built in protections for Nuvilex. But, is this investment really a risk? It appears the Chicago-based firm knows exactly what the future could hold for Nuvilex, and they're comfortable with paying a premium price to become a long-term investor right along with many others who believe in the small biotechnology firm.
